Air pollution kills over 8 million people annually, yet receives little media attention. Cities like London and New York are proving that data-driven solutions can drastically reduce pollution levels, offering a roadmap for global action.
En 2024, les tumeurs et maladies cardiovasculaires ont causé près de la moitié des 641 000 décès en France. Les tumeurs ont représenté 27,1% et les maladies circulatoires 21,2%. Les maladies respiratoires, hors Covid, ont progressé à 8,2%.
En 2024, plus de 641 000 décès ont été enregistrés en France, avec un taux de mortalité historiquement bas. Les cancers et maladies circulatoires restent les principales causes, mais les maladies respiratoires sont en hausse.
A new Drees study reveals significant social inequalities in cancer incidence and prognosis in France. The poorest populations face higher risks of developing aggressive cancers, receiving later diagnoses, and having poorer survival rates compared to the wealthiest.
France's National Assembly approved a bill to limit population exposure to cadmium, a toxic heavy metal. The law aims to reduce cadmium levels in phosphate fertilizers, which contaminate soil and food. The government opposed the bill's rapid reduction timeline, citing risks to French agriculture.
France's National Assembly overwhelmingly passed a bill to reduce health risks from cadmium contamination, a toxic metal found in common foods. The law, supported by scientists and civil society, sets a trajectory to lower maximum cadmium levels in phosphate fertilizers.
A new issue of the American Journal of Public Health reveals how tobacco companies like Philip Morris and RJ Reynolds used strategies developed for selling cigarettes to market ultra-processed foods (UPFs), including Lunchables, to children. These strategies focused on optimizing formulations for rapid reward and creating addictive products. UPFs are linked to increased risks of dementia, cognitive decline, cardiovascular diseases, and certain cancers.
Un nouveau médicament, le Daraxonrasib, double l'espérance de vie des patients atteints de cancer du pancréas métastatique, passant de 6,7 à 13,2 mois. Il cible la mutation du gène KRAS et pourrait être utilisé pour d'autres cancers.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
An experimental drug, GRWD5769, has shown promise in early trials by shrinking tumors by at least 30% in six common cancer types. The drug works by preventing cancer cells from hiding from the immune system, making immunotherapy treatments more effective.
Tulsi Gabbard avgår som chef för USA:s nationella underrättelsetjänst i juni. Hon uppger att beslutet beror på att hennes man diagnostiserats med cancer. Källor till Reuters hävdar dock att Vita huset tvingat henne att säga upp sig, möjligen på grund av hennes avvikande uttalanden om Iran.
Men's high consumption of red and processed meat, linked to chronic disease and climate pollution, is tied to cultural notions of masculinity. Experts suggest a "Meat me halfway" approach, reducing meat intake to weekly treats, to benefit both personal and planetary health.
A new study suggests GLP-1 drugs, known for weight loss and diabetes treatment, may slow the progression of certain obesity-related cancers. Comparing GLP-1 users to those on DPP-4 inhibitors, researchers found reduced cancer spread in lung, breast, colorectal, and liver cancers.
CAR-T cell therapy, a cancer treatment, is being repurposed for HIV. Early results show two individuals achieving undetectable viral loads and stopping HIV medication after a single infusion of engineered immune cells.
Pour sa deuxième édition en France, la campagne « Mai en gris » veut sensibiliser le grand public à ces cancers redoutables et difficiles à soigner, et soutenir la recherche.
A major analysis by the Institute of Cancer Research and Imperial College London reveals that eleven cancers are becoming more common in young people in England, including bowel, breast, thyroid, and ovarian cancers. While the exact cause remains unclear, the study found that rising levels of overweight and obesity since the 1990s are the only lifestyle factor aligning with the increase. Other known cancer risk factors like smoking, alcohol, and physical inactivity have been improving. The researchers emphasize cancer in young people remains rare, with one in 1,000 people in their 20s-40s diagnosed annually compared to one in 100 for older age groups.
A major analysis by the Institute of Cancer Research and Imperial College London reveals eleven cancers are becoming more common in young people in England. While the exact cause remains unknown, the study found that rising obesity rates since the 1990s are the only lifestyle factor aligning with the increase. For bowel cancer, researchers estimate 20 of 100 extra cases may be due to excess weight, leaving 80 cases unexplained. The study includes a case study of Bradley Coombes, who died at 23 from bowel cancer after an 18-month diagnostic delay.
A major analysis by the Institute of Cancer Research and Imperial College London reveals eleven cancers are becoming more common in young people in England. While the reason remains largely unexplained, the study found that rising obesity rates since the 1990s align with the trend. For bowel cancer, researchers estimate only 20 of 100 extra cases are linked to excess weight, leaving 80 unexplained. The findings include a case study of Bradley Coombes, who died at 23 from bowel cancer after an 18-month diagnostic delay.
An alarming new report has found liver cancer deaths have risen from 1.6 deaths per 100,000 people in the 1980s to 5.1 per 100,000 in 2018–2022.
Colorectal cancer rates are rising sharply among adults under 50, becoming the top cancer killer in this age group. Younger patients develop more aggressive tumors that are harder to treat despite aggressive chemotherapy and surgery. Experts suspect environmental factors — particularly gut microbiome disruption from ultra-processed foods, plastics and chemicals — may be driving this generational shift. While genetic factors explain about 20% of cases, the remaining 80% point to environmental causes. Current screening guidelines recommend starting at age 45, but patient advocates urge earlier testing for those with family history.
DÉCRYPTAGE - Une étude italienne a trouvé le mécanisme qui semble vraiment protéger les cellules cardiaques. Cela expliquerait à la fois pourquoi les métastases prennent rarement dans le cœur, mais aussi le taux extrêmement faible de cancers de cet organe vital.
DÉCRYPTAGE - Thales construira avec l’Institut Curie un nouveau type de machine de radiothérapie flash, qui devrait être capable d’épargner les tissus sains.
GSK has announced promising early-stage trial results for its cancer treatment Mo-Rez, which showed high efficacy in shrinking tumors for ovarian and endometrial cancer patients. The company plans to move directly to late-stage clinical trials.
